Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-22-037424

Chief People Officer acquired 3,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stants Kristen Chief People Officer 2022-11-30 Grant or award +3,000 $0.94 $2,820 20,264 D
Loading xslF345X03/doc4.xml…